Pharsight

BRISTOL MYERS SQUIBB PATENTS FACING OPPOSITIONS

Top patents of BRISTOL MYERS SQUIBB facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3246021B1 13 Nov, 2019 Apixaban Formulations NA 12
EP3322731B1 13 Jan, 2021 Method Of Treating Cancer Using Immune Checkpoint Inhibitor Jul, 2036 10
EP3251660B1 16 Oct, 2019 Apixaban Formulations NA 10
EP3257500B1 16 Oct, 2019 Apixaban Formulations NA 10
EP3017811B1 05 Dec, 2018 Apixaban Formulations NA 9
EP3464373B1 27 Oct, 2021 Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer Jun, 2037 6
EP3288980B1 10 Mar, 2021 Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody Apr, 2036 5
EP2906683B1 31 May, 2017 Mammalian Cell Culture Processes For Protein Production NA 2
EP2925350B1 30 Jan, 2019 Enhancing Anti-Cancer Activity Of Immunomodulatory Fc Fusion Proteins NA 1
EP3054926B1 25 Jul, 2018 Hiv Treatment Formulation Of Atazanavir And Cobicistat NA 1